Hadassah

Hadassah Receives $6.5 Million Grant to Create Translational Medicine Institute

Monday, Feb 2 2015

Left to right: Mark Addleman, Executive Director, Hadassah UK; Guilda Shamash, Past Chair, Hadassah UK; Melissa Kaplan, Director, Hadassah International; Sir Ian Gainsford, Hadassah UK Advisory Committee and Hadassah International Board of Directors; Prof. Tamar Peretz, Interim Director, HMO; Dr. Linda Greenwall, Hadassah UK Trustee; and Jean Jacque Roboh, Hadassah UK Trustee.

Hadassah is delighted to start the new year with the announcement of a $6,500,000 grant to the Hadassah Medical Organization (HMO) from the Wohl Legacy Foundation in the UK to create the Wohl Institute for Translational Medical Researchone of the foundation's medicine and arts 50th anniversary celebratory grants, commemorating 50 years of giving.

Prof. Tamar Peretz, Acting Director General of HMO, who traveled to London to participate in the awards ceremony, noted that translational medicine brings the benefits of science back to the patient, with better technology to create improved infrastructure. In contrast to 15 years ago when science was undertaken only in the university setting, with translational medicine, scientific and medical needs can be defined at the individual patient level, then transferred from the patient to the laboratory to find a solution. The research results then flow back to the patient. This process allows a quicker transfer of knowledge and clinical application, resulting in better quality patient care.

The new Wohl Centre for Translational Medicine at Hadassah will look particularly into how diseases begin and progress, the development of drugs for specific diseases, and how individual patients benefit from different treatments and drug regimens. Physician/researchers will especially focus their work on cancers, multi-genes, Parkinson's, ALS, and other degenerative diseases.

The trustees of The Wohl Legacy Foundation believe that investing in translational medicine is vital to developing the most effective therapies for these complex diseases. This new Institute at Hadassah will bolster the hospital's team of clinicians and biomedical researchers with access to open laboratory space and cutting-edge scientific technology. It is their belief that Hadassah will provide a dramatic stimulus to translational medicine, and will help meet global clinical needs. The award was given to Hadassah because its history is one of scientific development and it continues to generate the highest number of research papers emanating from one institution in Israel.

Maurice Wohl, a rabbi's son, was born and raised in London. His faith and upbringing played a huge part in the evolution of his philanthropy. Prior to Vivienne's death from cancer in 2005 at the age of 59, they decided to establish the Maurice and Vivienne Wohl Philanthropic Foundation as a reflection of their lifetime of philanthropic activity. Maurice died in 2007, at age 90. He was buried in Jerusalem next to his beloved wife.

At the awards ceremony on January 29th, along with the announcements of the grant recipients, the Wohl Lecture was delivered by His Excellency Matthew Gould, Britain's Ambassador to Israel. In his remarks, the Ambassador said: "It is a real honor to give the Wohl lecture in the philanthropy's 50th Anniversary year. I feel passionately that the Jewish community here can have a huge and positive impact on relations between Britain and Israel. Jewish philanthropy tied together with Israeli creativity has achieved amazing things in Israel, and is still doing so. Maurice and Vivienne Wohl were models for giving that makes a difference.”

Comments

From: Sherri on March 16, 2015
Great news, I am so proud of Hadassah and the work we do!
First Name
Email
Comment
Enter this word:

Related Stories

Tuesday, Jun 12 2018

Hadassah Ophthalmology Department Research Highlighted by JAMA

Thanking the Hadassah Medical Organization’s researchers for their ”excellent submission” to JAMA Ophthalmology regarding a multi-center international study of the variable effectiveness of treatment for neovascular age-related macular degeneration (nAMD), the editors explained that their article was one of just a few from 12 JAMA on-line journals to be highlighted in The JAMA Network Reader this weekend.

READ MORE ›
alt_text

Monday, Jun 11 2018

Ruth Radiano: Passionate New Director of Nursing at Hadassah Hospital Mount Scopus

Translating her passion and professionalism into action, Ruth Radiano, the new Director of Nursing at Hadassah Hospital Mount Scopus, brings a background of 26 years of nursing at Hadassah.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Former NYC Mayor Giuliani Calls Hadassah Hospital a Blessing

Former New York City Mayor Rudy Giuliani and his partner Dr. Maria Ryan, CEO of Cottage Hospital in Woodsville, New Hampshire visited Hadassah Medical Organization in Jerusalem today to get an update on Hadassah’s management of terror events.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Hadassah Researchers Develop Definitive Biomarker for Cardiac Muscle Death and Link it to Death from Sepsis

Hadassah Medical Organization researchers, in collaboration with colleagues at the Hadassah-Hebrew University School of Medicine, have developed a blood test which definitively detects death of cardiac muscle cells following an acute heart attack and in the case of sepsis.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More